shr-1316
Showing 1 - 9 of 9
Advanced Solid Tumors Trial in Perth (SHR-1316)
Completed
- Advanced Solid Tumors
- SHR-1316
-
Perth, West Australia, AustraliaLinear Clinical Research
Jul 11, 2022
Tumor Trial (SHR-1316)
Not yet recruiting
- Tumor
- SHR-1316
- (no location specified)
Jul 16, 2021
Breast Cancer, Metastatic Cancer Trial (SHR-1316, SHR6390, Nab paclitaxel)
Not yet recruiting
- Breast Cancer
- Metastatic Cancer
- SHR-1316
- +4 more
- (no location specified)
Jan 11, 2022
Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)
Not yet recruiting
- Breast Neoplasm
- +9 more
- Dalpiciclib
- +15 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 13, 2022
Limited-stage Small Cell Lung Cancer, LS-SCLC Trial (SHR-1316)
Not yet recruiting
- Limited-stage Small Cell Lung Cancer, LS-SCLC
- SHR-1316
- (no location specified)
Nov 27, 2020
Small Cell Lung Cancer Trial in Chengdu (Fluzoparib, temozolomide, SHR-1316)
Unknown status
- Small Cell Lung Cancer
- Fluzoparib
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Jun 19, 2020
Advanced Esophageal Squamous Cell Cancer Trial in Beijing (Irinotecan liposome, SHR-1316, Fluorouracil)
Unknown status
- Advanced Esophageal Squamous Cell Cancer
- Irinotecan liposome
- +2 more
-
Beijing, Beijing, ChinaCancer Institute and Hospital,Chinese Academy of Medical Science
Nov 5, 2018
Tumor Trial in Shanghai (SHR-1316)
Unknown status
- Tumor
- SHR-1316
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2018